BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15583798)

  • 1. Somatostatin receptor scintigraphy in metastatic breast cancer patients.
    Mezi S; Primi F; Orsi E; Capoccetti F; Scopinaro F; Schillaci O
    Oncol Rep; 2005 Jan; 13(1):31-5. PubMed ID: 15583798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
    Reisinger I; Bohuslavitzki KH; Brenner W; Braune S; Dittrich I; Geide A; Kettner B; Otto HJ; Schmidt S; Munz DL
    J Nucl Med; 1998 Feb; 39(2):224-7. PubMed ID: 9476922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
    Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
    Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
    Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
    J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor scintigraphy in advanced renal cell carcinoma. Results of a phase II-trial of somatostatine analogue therapy in patients with advanced RCC.
    Freudenberg LS; Gauler T; Görges R; Bauer S; Stergar H; Antoch G; Bockisch A; Schütte J
    Nuklearmedizin; 2008; 47(3):127-31. PubMed ID: 18493693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
    Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
    J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
    Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
    J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma.
    Friedberg JW; Van den Abbeele AD; Kehoe K; Singer S; Fletcher CD; Demetri GD
    Cancer; 1999 Oct; 86(8):1621-7. PubMed ID: 10526294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
    Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL
    Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
    Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
    J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
    Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C
    J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
    Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
    J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic indium-111-pentetreotide scintigraphy in breast cancer.
    Bajc M; Ingvar C; Palmer J
    J Nucl Med; 1996 Apr; 37(4):622-6. PubMed ID: 8691252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
    Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
    Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.
    Leboulleux S; Dromain C; Vataire AL; Malka D; Aupérin A; Lumbroso J; Duvillard P; Elias D; Hartl DM; De Baere T; Guigay J; Schlumberger M; Ducreux M; Baudin E
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3021-8. PubMed ID: 18522978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
    Schillaci O; Corleto VD; Annibale B; Scopinaro F; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT; Gibril F
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.